[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 918153, "exercisedValue": 0, "unexercisedValue": 148377}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 695443, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1206766, "exercisedValue": 0, "unexercisedValue": 590310}, {"maxAge": 1, "name": "Dr. Kenneth E. Johnson Pharm. D., Pharm.D.", "age": 61, "title": "Senior VP of Global Development & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 596967, "exercisedValue": 0, "unexercisedValue": 31173}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.56, "open": 4.59, "dayLow": 4.5001, "dayHigh": 4.89, "regularMarketPreviousClose": 4.56, "regularMarketOpen": 4.59, "regularMarketDayLow": 4.5001, "regularMarketDayHigh": 4.89, "payoutRatio": 0.0, "beta": 1.208, "forwardPE": -21.909092, "volume": 6570525, "regularMarketVolume": 6570525, "averageVolume": 2036938, "averageVolume10days": 4413340, "averageDailyVolume10Day": 4413340, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 741990848, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 4.9, "priceToSalesTrailing12Months": 3.6538675, "fiftyDayAverage": 3.6888, "twoHundredDayAverage": 3.011, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 941817472, "profitMargins": -0.27003, "floatShares": 146317020, "sharesOutstanding": 153940000, "sharesShort": 10633524, "sharesShortPriorMonth": 10485254, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0691, "heldPercentInsiders": 0.039920002, "heldPercentInstitutions": 0.42865002, "shortRatio": 5.88, "shortPercentOfFloat": 0.070700005, "impliedSharesOutstanding": 153940000, "bookValue": -0.198, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54836000, "trailingEps": -0.37, "forwardEps": -0.22, "enterpriseToRevenue": 4.638, "enterpriseToEbitda": -60.857, "52WeekChange": 1.2629108, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 4.82, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.08333, "targetMedianPrice": 6.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 71621000, "totalCashPerShare": 0.465, "ebitda": -15476000, "totalDebt": 271447008, "quickRatio": 1.115, "currentRatio": 1.669, "totalRevenue": 203070000, "revenuePerShare": 1.384, "returnOnAssets": -0.05333, "grossProfits": 166238000, "freeCashflow": -27807376, "operatingCashflow": -36981000, "revenueGrowth": 0.354, "grossMargins": 0.81861997, "ebitdaMargins": -0.07621, "operatingMargins": 0.12944001, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1741995518, "regularMarketTime": 1741982400, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 5.7017593, "regularMarketPrice": 4.82, "cryptoTradeable": false, "postMarketChangePercent": -0.414937, "postMarketPrice": 4.8, "postMarketChange": -0.02, "regularMarketChange": 0.26000023, "regularMarketDayRange": "4.5001 - 4.89", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2036938, "fiftyTwoWeekLowChange": 3.13, "fiftyTwoWeekLowChangePercent": 1.852071, "fiftyTwoWeekRange": "1.69 - 4.9", "fiftyTwoWeekHighChange": -0.07999992, "fiftyTwoWeekHighChangePercent": -0.016326515, "fiftyTwoWeekChangePercent": 126.291084, "earningsTimestamp": 1741262400, "earningsTimestampStart": 1746702000, "earningsTimestampEnd": 1747047600, "earningsCallTimestampStart": 1741267800, "earningsCallTimestampEnd": 1741267800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.22, "epsCurrentYear": -0.1, "priceEpsCurrentYear": -48.2, "fiftyDayAverageChange": 1.1312001, "fiftyDayAverageChangePercent": 0.306658, "twoHundredDayAverageChange": 1.8090003, "twoHundredDayAverageChangePercent": 0.6007972, "priceToBook": -24.343435, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-03-14", "averageAnalystRating": "1.5 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]